News

Filter

Current filters:

Angelini

Durata out-licenses dalbavancin to Angelini for certain territories

Durata out-licenses dalbavancin to Angelini for certain territories

30-07-2014

USA-based Durata Therapeutics says its Dutch subsidiary entered into a license and supply agreement with…

AngeliniAntibiotics and Infectious diseasesDalvanceDurata TherapeuticsEuropeLicensingPharmaceutical

Helsinn and Angelini ink licensing deal for anamorelin

15-01-2014

Privately-held Swiss pharma group Helsinn has granted exclusive distribution and licensing rights for…

anamorelinAngeliniEastern EuropeHelsinnLicensingOncologyPharmaceutical

APR and Angelini partner on wound management product

20-12-2013

Privately-held Italian drugmaker Angelini and Switzerland-based health care group Applied Pharma Research…

AmuphaseAngeliniApplied Pharma ResearchDermatologicalsEuropeLicensingNexodynPharmaceutical

Angelini Labopharm launch of Oleptro in USA for major depressive disorder in adults

10-08-2010

Angelini Labopharm announced yesterday that its antidepressant Oleptro (trazodone hydrochloride extended-release…

AngeliniLabopharmMarkets & MarketingNeurologicalOleptroPharmaceutical

Labopharm and Angelini set up JV to commercialize Oleptro in USA

04-05-2010

Canada’s Labopharm and privately-owned Gruppo Angelini of Italy have entered into an agreement to…

AngeliniFinancialLabopharmLicensingNeurologicalOleptroPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top